Literature DB >> 6135665

Monoclonal immunoglobulin M antibody to Japanese encephalitis virus that can react with a nuclear antigen in mammalian cells.

E A Gould, A C Chanas, A Buckley, C S Clegg.   

Abstract

An immunoglobulin M (IgM) class monoclonal antibody raised against Japanese encephalitis virus reacted with an epitope on the nonstructural virus protein P74 (NV4 in the old nomenclature) of several flaviviruses and also with an antigen present in the nuclei of a variety of mammalian cell types. This antigen had a characteristic granular distribution by immunofluorescence and may correspond to a polypeptide of molecular weight 56,000 seen in nitrocellulose transfers of sodium dodecyl sulfate-polyacrylamide gels. Cross-reactivity with nuclear antigen was also occasionally observed in the IgM antibody fraction of mice early after infection with Japanese encephalitis virus and also in acute sera from some clinical cases of encephalitis containing IgM antibody to Japanese encephalitis virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135665      PMCID: PMC264707          DOI: 10.1128/iai.41.2.774-779.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  THE OCCURENCE OF RHEUMATOID FACTOR IN ASSOCIATION WITH ANTIBODY RESPONSE TO INFLUENZA A2(ASIAN) VIRUS.

Authors:  K H SVEC; J H DINGLE
Journal:  Arthritis Rheum       Date:  1965-08

3.  Rubella arthritis; report of cases studied by latex tests.

Authors:  R E JOHNSON; A P HALL
Journal:  N Engl J Med       Date:  1958-04-10       Impact factor: 91.245

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Antibodies against -globulin after blood transfusion and cytomegalovirus-infection.

Authors:  M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Molecular recognition and the future of monoclonal antibodies.

Authors:  D Lane; H Koprowski
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

8.  Glycoprotein detection in nitrocellulose transfers of electrophoretically separated protein mixtures using concanavalin A and peroxidase: application to arenavirus and flavivirus proteins.

Authors:  J C Clegg
Journal:  Anal Biochem       Date:  1982-12       Impact factor: 3.365

9.  SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000.

Authors:  D P Lane; W K Hoeffler
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

View more
  4 in total

1.  Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues.

Authors:  J Srinivasappa; J Saegusa; B S Prabhakar; M K Gentry; M J Buchmeier; T J Wiktor; H Koprowski; M B Oldstone; A L Notkins
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

2.  Three monoclonal antibodies against measles virus F protein cross-react with cellular stress proteins.

Authors:  H Sheshberadaran; E Norrby
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

Review 3.  Virus-related pathology: is the continued presence of the virus necessary?

Authors:  J Huppert; T F Wild
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

4.  Characterization of Kunjin virus RNA-dependent RNA polymerase: reinitiation of synthesis in vitro.

Authors:  P W Chu; E G Westaway
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.